ABSTRACT
Introduction Depression is a non-motor symptom of Parkinson’s disease (PD). PD-related depression is hard to diagnose and the neurophysiological basis is poorly understood. Depression can markedly affect cortical function, which suggests that scalp electroencephalography (EEG) may be able to distinguish depression in PD.
Methods We recruited 18 PD patients, 18 PD patients with depression, and 12 demographically-similar non-PD patients with clinical depression. All patients were on their usual medications. We collected resting-state EEG in all patients and compared cortical brain signal features between patients with and without depression. We used a machine-learning algorithm that harnesses the entire power spectrum (linear predictive coding of EEG Algorithm for PD: LEAPD), to distinguish between groups.
Result We found differences between PD patients with and without depression in the alpha band (8-13 Hz) globally and in the beta (13-30 Hz) and gamma (30-80 Hz) bands in the central electrodes. From two minutes of resting-state EEG we found that LEAPD-based machine learning could robustly distinguish between PD patients with and without depression with 97% accuracy, and between PD patients with depression and non-PD patients with depression with 100% accuracy. We verified the robustness of our finding by confirming that the classification accuracy declines gracefully as data are truncated.
Conclusions We demonstrated the efficacy of the LEAPD algorithm in identifying PD patients with depression from PD patients without depression and controls with depression. Our data provide insight into cortical mechanisms of depression and could lead to novel neurophysiologically-based biomarkers for non-motor symptoms of PD.
HIGHLIGHTS
We used EEG to analyze depression in Parkinson’s disease.
Depressed Parkinson’s patients had distinct spectral EEG features.
Machine-learning algorithms could accurately distinguish depression in Parkinson’s disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the US Department of Health & Human Services, National Institutes of Health OR This data was supported by NIH P20NS123151 and R01NS100849 to NSN
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB-01 of the University of Iowa gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
